Instruments

Name Stock exchange Average volume Price Type
THE SEIBELS BRUCE GROUP, INC. SBBG

OTC Markets

9 0.05 USD Stock The Seibels Bruce Group, Inc. Stock

News (336)

Transcript : Jazz Pharmaceuticals plc Presents at Bank of America Health Care Conference 2024, May-15-2024 10:00 AM
ACELYRIN, INC. Announces Leadership Transition GL
Transcript : Jazz Pharmaceuticals plc, Q1 2024 Earnings Call, May 01, 2024
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance PR
Nippon Shinyaku : Vyxeos® Combination for I.V. Injection Receives Approval for the Treatment of High-risk AML in Japan PU
Acelyrin : Corporate Presentation PU
Transcript : Jazz Pharmaceuticals plc - Special Call
Transcript : Jazz Pharmaceuticals plc Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 10:30 AM
Transcript : Jazz Pharmaceuticals plc, Q4 2023 Earnings Call, Feb 28, 2024
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance PR
Jazz Pharmaceuticals Appoints Patrick Kennedy to its Board of Directors PR
Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer PR
Transcript : Jazz Pharmaceuticals plc Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 02:15 PM
Jazz Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference PR
Transcript : Jazz Pharmaceuticals plc, Q3 2023 Earnings Call, Nov 08, 2023
Jazz Pharmaceuticals Announces Third Quarter 2023 Financial Results and Updates Financial Guidance PR
Jazz Pharmaceuticals Announces Key Update to Leadership Team AQ
Jazz Pharmaceuticals Announces Second Quarter 2023 Financial Results and Raises 2023 Full Year Financial Guidance AQ
Transcript : Jazz Pharmaceuticals plc, Q2 2023 Earnings Call, Aug 09, 2023
Nippon Shinyaku : Submission of New Drug Application for NS-87 (daunorubicin and cytarabine liposome injection) in Japan PU
Transcript : Jazz Pharmaceuticals plc Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-13-2023 03:20 PM
Transcript : Jazz Pharmaceuticals plc - Special Call
Transcript : Jazz Pharmaceuticals plc Presents at RBC Capital Markets Global Healthcare Conference 2023, May-16-2023 04:05 PM
Transcript : Jazz Pharmaceuticals plc, Q1 2023 Earnings Call, May 10, 2023
Jazz Pharmaceuticals Announces First Quarter 2023 Financial Results and Affirms 2023 Financial Guidance PR
Transcript : Jazz Pharmaceuticals plc Presents at Cowen 43rd Annual Healthcare Conference, Mar-07-2023 12:50 PM
Transcript : Jazz Pharmaceuticals plc, Q4 2022 Earnings Call, Mar 01, 2023
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2022 Financial Results and Provides 2023 Financial Guidance PR
Transcript : Jazz Pharmaceuticals plc Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 03:45 PM
Jazz Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference PR
Transcript : Jazz Pharmaceuticals plc Presents at 5th Annual Evercore ISI HealthCONx Conference 2022, Nov-29-2022 01:50 PM
Transcript : Jazz Pharmaceuticals plc, Q3 2022 Earnings Call, Nov 09, 2022
Jazz Pharmaceuticals Announces Third Quarter 2022 Financial Results and Raises Total Revenue Guidance Mid-point PR
Jazz Pharmaceuticals : Announces Second Quarter 2022 Financial Results and Affirms 2022 Financial Guidance - Form 8-K PU
Transcript : Jazz Pharmaceuticals plc, Q2 2022 Earnings Call, Aug 03, 2022
Transcript : Jazz Pharmaceuticals plc Presents at Bank of America 2022 Healthcare Conference, May-10-2022 12:40 PM
Jazz Pharmaceuticals Completes U.S. Divestiture of Sunosi (solriamfetol) to Axsome Therapeutics AQ
Jazz Pharmaceuticals Completes U.S. Divestiture of Sunosi® (solriamfetol) to Axsome Therapeutics PR
Jazz Pharmaceuticals Announces First Quarter 2022 Financial Results and Raises 2022 Financial Guidance AQ
Transcript : Jazz Pharmaceuticals plc, Q1 2022 Earnings Call, May 04, 2022
Transcript : Radius Health, Inc. - Special Call
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi (solriamfetol) to Axsome Therapeutics AQ
Jazz Pharmaceuticals : Announces Agreement to Divest Sunosi® (solriamfetol) to Axsome Therapeutics - Form 8-K PU
Axsome Therapeutics : to Acquire Sunosi® from Jazz Pharmaceuticals, Expanding Axsome’s Leadership in Neuroscience - Form 8-K PU
Jazz Pharmaceuticals Announces Significant New Investment in UK Manufacturing AQ
1234NextSee all

Companies (12)

SERICA ENERGY PLC 908 M $
Logo Serica Energy plc

Serica Energy plc is a mid-tier independent oil and gas company. The principal activity of the Company and its subsidiaries is to identify, acquire, explore and subsequently exploit oil and gas reserves. Its activities are located in the United Kingdom (U ...

METALSGROVE MINING LIMITED 2 M $
Logo MetalsGrove Mining Limited

MetalsGrove Mining Limited is an exploration and development company. The Company is engaged in the exploration and development of its portfolio of lithium, rare earth, copper-gold, manganese, and base metal projects in Western Australia (WA) and the Nort ...

EQUINOX RESOURCES LIMITED 20 M $
Logo Equinox Resources Limited

Barrick Resources (Australia) Pty Ltd, formerly Equinox Resources Pty Limited, is an Australia-based mineral exploration company. The Company is formed for the purpose of acquiring the Hamersley Iron Ore Project. The Hamersley Iron Ore Project is located ...

CARAVEL MINERALS LIMITED 91 M $
Logo Caravel Minerals Limited

Caravel Minerals Limited is an Australia-based company, which is engaged in the exploration of mineral tenements in Western Australia. The Company’s Caravel Copper Project is located 150 kilometers north-east of Perth in Western Australia’s Wheatbelt ...

LIKEWISE GROUP PLC 51 M $
Logo Likewise Group Plc

Likewise Group Plc is a United Kingdom-based floor coverings distributor. The Company is engaged in the wholesale distribution of floor coverings and associated products. It is focused on the residential and commercial areas of the market. Its distributio ...

AUQ GOLD MINING INC. 2 M $
Logo AuQ Gold Mining Inc.

AUQ Gold Mining Inc. is a Canada-based exploration company. The company is engaged in the acquisition, exploration and development of mineral property assets. The Company owns Lac Bruce lithium properties, which is located in the vicinity of the Mia Li-1 ...

AVANT BRANDS INC. 16 M $
Logo Avant Brands Inc.

Avant Brands Inc. is a Canada-based cannabis company. The Company produces handcrafted cannabis products. Its products are distributed via three sales channels: recreational, medical and export. The Company's recreational brand portfolio includes BLK MKT, ...

TAPINATOR, INC. 1 M $
Logo Tapinator, Inc.

Tapinator, Inc. develops and publishes games for mobile platforms. The Company’s portfolio includes over 300 titles that have over 500 million mobile downloads, including games such as Video Poker Classic and Crypto Trillionaire. It publishes two types ...

THE SEIBELS BRUCE GROUP, INC. 268 $
Logo The Seibels Bruce Group, Inc.

The Seibels Bruce Group, Inc. is engaged in providing business process outsourcing solutions and third-party administration services to the property and casualty insurance industry. The Company’s claims services include multi-line desk adjusting and fie ...

TYHEE GOLD CORP. 439 $
Logo Tyhee Gold Corp.

Tyhee Gold Corp. is a mineral exploration company. The Company is engaged in the development of its Yellowknife Gold Project (YPG) in Canada's Northwest Territories. It evaluates and acquires operating or near-term operating gold properties in North Ameri ...


12Next

Insiders

Picture Bruce Cozadd
Bruce Cozadd

Bruce C. Cozadd is a businessperson who founded Jazz Pharmaceuticals Plc and Jazz Pharmaceuticals, Inc. and who has been at the head of 5 different companies. Mr. Cozadd is Chairman for The Nueva School and Chairman & Chief Executive Officer for Jazz Pharmaceuticals Plc, Chairman & Chief Executive Officer for Jazz Pharmaceuticals, Inc. (a subsidiary of Jazz Pharmaceuticals Plc). Mr. Cozadd is also on the board of Biotechnology Innovation Organization, Pharmaceutical Research & Manufacturers of America and SFJAZZ. In the past Mr. Cozadd was Chairman & Chief Executive Officer for Azur Pharma Ltd., President & Director at Celator Pharmaceuticals, Inc., Chief Operating Officer & Executive Vice President of ALZA Corp., Member-Health Care Investment Banking Team at Smith Barney Harris Upham & Co., Inc. and Member of Harris Upham & Co, Inc. Bruce C. Cozadd received an undergraduate degree from Yale University and an MBA from Stanford Graduate School of Business.


Picture Gail Cozadd
Gail Cozadd

Gail Cozadd currently works as the Chief Executive Officer at Kansas Children's Service League.



Picture David Cozadd
David Cozadd

David Cozadd currently works at Burke Center, as Secretary & Trustee from 2012.






Picture Jim R. Bruce
Jim R. Bruce

Mr. Jim R.
Bruce
is Vice President at Nottingham Advisors, Inc. He joined Nottingham Advisors in May 2010.
He began his career in the investment business in 1995 as a financial advisor with A.G.
Edwards.
In 2002, Mr. Bruce joined Hartford Insurance to wholesale their annuity products.
Mr. Bruce graduated with a degree in Finance from Canisius College in Buffalo, NY in 1993.


Picture Bruce K. Dudley
Bruce K. Dudley

Bruce K.
Dudley
is currently the Director at The Home of the Innocents, Inc. He previously worked as the Director at New Covenant Trust Co., NA.
He completed his undergraduate degree at Transylvania University in 1976 and his graduate degree at the University of Louisville in 1980.

No results for this search

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW